A clinical-stage biotechnology company that developed vaccine-based immunotherapies directing T cells against tumor neoantigens and viral antigens.
Gritstone bio / Sarah Cannon Research Institute
Released December 10, 2024
HLA class II presentation and CD4 epitope prediction from peptide sequence, built on a protein language model with learned allele deconvolution.